Literature DB >> 7625650

Designing peptide vaccines to broaden recognition and enhance potency.

J A Berzofsky1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7625650     DOI： 10.1111/j.1749-6632.1995.tb44449.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  10 in total

1.  Getting peptide vaccines to work: just a matter of quality control?

Authors:  Esteban Celis
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  Strategies to use immune modulators in therapeutic vaccines against cancer.

Authors:  Jay A Berzofsky; Masaki Terabe; Lauren V Wood
Journal:  Semin Oncol       Date:  2012-06       Impact factor: 4.929

Review 3.  A push-pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses.

Authors:  Jay A Berzofsky
Journal:  Vaccine       Date:  2011-11-21       Impact factor: 3.641

4.  Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens.

Authors:  K R Irvine; M R Parkhurst; E P Shulman; J P Tupesis; M Custer; C E Touloukian; P F Robbins; A G Yafal; P Greenhalgh; R P Sutmuller; R Offringa; S A Rosenberg; N P Restifo
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

5.  Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.

Authors:  P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

6.  Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence.

Authors:  J D Ahlers; T Takeshita; C D Pendleton; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 7.  Cancer vaccines: translation from mice to human clinical trials.

Authors:  Hoyoung Maeng; Masaki Terabe; Jay A Berzofsky
Journal:  Curr Opin Immunol       Date:  2018-03-16       Impact factor: 7.486

8.  Evolutionary Analysis and Prediction of Peptide Vaccine Candidates for Foot-and-Mouth-Disease Virus Types A and O in Bangladesh.

Authors:  Samina Momtaz; Arafat Rahman; Munawar Sultana; M Anwar Hossain
Journal:  Evol Bioinform Online       Date:  2014-11-03       Impact factor: 1.625

Review 9.  Strategies for developing and optimizing cancer vaccines.

Authors:  Hoyoung M Maeng; Jay A Berzofsky
Journal:  F1000Res       Date:  2019-05-13

10.  Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses.

Authors:  So-Yon Lim; Matt Meyer; Richard A Kjonaas; Swapan K Ghosh
Journal:  J Immune Based Ther Vaccines       Date:  2006-10-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.